News Chart Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
2.1 ^USD	+7.14%		+7.69%	+13.51%

May. 07	Cognition Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Cognition Therapeutics, Inc. Completes Enrollment in Phase 2 SHIMmer Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies	CI

80ed76ce5962ef3.DtZJXFi7EKwRW5QbYG8eS-Q91GnHgHID6ly2S00RJTk.V5UrEA3rJtxzMNt4JShGIapPkBih8yNpkmWHHDllFnM4kBMaAvlc9VQIrA~b317ced1d53a05daab90bcfa84ec122a